9 publications
-
Published Subscription
Role of Axillary Reverse Mapping in Reducing the Risk of Lymphedema in Breast Cancer Patients: Current PerspectivesBy D. K. Vijay kumar
Abstract: Axillary reverse mapping is the technique of mapping and subsequently preserving the arm lymphatic drainage during axillary dissection. In 2007 Hiroo Suami described a constant sentry node draining most of the upper limb in anatomical dissection of cadavers. The presence of this node and its fairly constant location was later confirmed by many authors in clinical studies. With the use of blue dye alone, the detection rates are low than …
Published in Research and Reviews: Journal of Oncology and Hematology · Vol. 6, Issue 1, 2017 · pp. 6–10 Read article →
-
Published Subscription
Pattern of Care and Pattern of Survival Study in ca Cervix: Implications of a Published StudyBy D. K. Vijay kumar, Shivdas S
Abstract: This article is being written in the context of the recently published multi-institutional study of POSCC for patients of cervical cancer in India. This study involves both private and public funded institutions and has hospitals from most parts of the country. This study is of utmost relevance in current day India, since India alone accounts for one-fourth of the total burden of disease. Stage I cervical cancer has a fairly …
Published in Research and Reviews: Journal of Oncology and Hematology · Vol. 4, Issue 3, 2015 · pp. 14–18 Read article →
-
Published Subscription
Adult Granulosa Cell Tumor of Ovary (GCT) – A Practical ApproachBy D. K. Vijay kumar, Michelle Aline Antony
Abstract: Granulosa cell tumor (GCTs) are a rare group of tumors constituting less than 5% of all ovarian tumors and account for more than 70% of the sex cord-stromal tumors. They present with features of hypere-strogenism and are characterized by a good response to surgery but are notorious for late recurrences. Lifelong surveillance with serial clinical examination and tumor markers is advised. Adjuvant therapy, usually with BEP, is offered in high-risk …
Published in Research and Reviews: Journal of Oncology and Hematology · Vol. 2, Issue 1, 2013 · pp. 1–5 Read article →
-
Published Subscription
Adjuvant Treatment in Carcinoma of Endometrium: Where Do We Stand?By D. K. Vijay kumar, Beena Kunheri, Anand RK
Abstract: Endometrial cancer is one of the most common gynecological malignancy worldwide. Though there are a large number of completed prospective and retrospective studies, adjuvant treatment remains poorly defined, mainly due to the heterogeneity in selection criteria, different treatment approaches and low recurrence rates in good risk early stage disease. This article comprehensively covers the different risk stratification approaches and the current concepts and evidences in tailoring of adjuvant treatment in …
Published in Research and Reviews: Journal of Oncology and Hematology · Vol. 5, Issue 3, 2016 · pp. 22–29 Read article →
-
Published Subscription
Management of Axilla in Breast Cancer: Reducing Morbidity of Axillary DissectionBy D. K. Vijay kumar
Abstract: The main role of axillary dissection for breast cancer is in deciding the nature of adjuvant therapy. Its role in improving overall survival is still not proven. Lymphedema is the most dreaded morbidity of axillary dissection. While sentinel node biopsy may help reduce this considerably, this is possibly more applicable in countries that have a regular screening program and plenty of screen-detected cancers. In India, we get most patients with …
Published in Research and Reviews: Journal of Oncology and Hematology · Vol. 1, Issue 1, 2012 · pp. 1–5 Read article →
-
Published Subscription
Role of Ca125 Monitoring in Post Treatment Epithelial Ovarian Cancer PatientsBy D. K. Vijay kumar
Abstract: The role of routine CA125 monitoring after therapy in epithelial ovarian CA has been questioned after the results of the MRC OV-05/EORTC 55985 study have been published. However, the role of hormonal agents like Tamoxifen or Letrezole in the setting of asymptomatic rise in CA125 has not been addressed in this study, as the treatment group received second-line chemotherapy. The GOG has looked into the role of Tamoxifen and also …
Published in Research and Reviews: Journal of Oncology and Hematology · Vol. 4, Issue 2, 2015 · pp. 17–20 Read article →
-
Published Subscription
Sentinel Node Mapping in Endometrial Cancer with Radioactive Colloid Injection: A Feasibility StudyBy D. K. Vijay kumar, Roopesh N., Anupama Rajanbabu, Shanmuga Sundaram P., Arun B. R.
Abstract: Role of lymphadenectomy in endometrial cancer is a much-debated one. Sentinel node mapping procedure attempts to minimize the morbidity of lymphadenectomy while providing the required prognostic information. In this study, we are attempting to detect the feasibility of SLN detection in early endometrial cancer by using radioactive technetium colloid injection. This is a prospective non-randomized single-institution study where patients with apparently early endometrial cancer without enlarged lymph nodes underwent preoperative …
Published in Research and Reviews: Journal of Oncology and Hematology · Vol. 4, Issue 2, 2015 · pp. 13–16 Read article →
-
Published Subscription
A Rare Case of Signet-Ring Cell Stromal Tumor (SRST) of the OvaryBy D. K. Vijay kumar, Roopesh N., Nair Indu R., Anupama R.
Abstract: Signet Ring-Cell Stromal Tumor (SRST) of the ovary is a rare nonfunctioning distinctive stromal neoplasm and is characterized by a proliferation of stromal and signet-ring cells. To date, only 11 cases have been reported in English literature. The tumor is characterized by a proliferation of stromal spindle cells in the form of a typical fibroma, admixed with various amounts of stromal cells with a single large vacuole and eccentric nuclei, …
Published in Research and Reviews: Journal of Oncology and Hematology · Vol. 4, Issue 2, 2015 · pp. 4–7 Read article →
-
Published Subscription
Changing Trends in Advanced Epithelial Ovarian Cancer - A ReviewBy D. K. Vijay kumar, Anupama Rajanbabu
Abstract: Despite the advances in surgery and chemotherapy, the outcome of patients affected with advanced epithelial ovarian cancer continues to be poor. Now researchers are looking at ovarian cancer through newer perspectives so as to find better treatment modalities that can improve overall survival (OS). In this chapter, we have briefly reviewed the newer areas of research in epithelial ovarian cancer. We look at how better understanding of the molecular biology, …
Published in Research and Reviews: Journal of Oncology and Hematology · Vol. 3, Issue 2, 2014 · pp. 1–7 Read article →